# Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

> **NCT02305888** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 189 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** LEO 43204

## Key facts

- **NCT ID:** NCT02305888
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02305888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02305888, "Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02305888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*